Literature DB >> 26774035

Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity.

Angela Di Capua1, Claudia Sticozzi2, Simone Brogi1, Margherita Brindisi1, Andrea Cappelli1, Lidia Sautebin3, Antonietta Rossi3, Simona Pace3, Carla Ghelardini4, Lorenzo Di Cesare Mannelli4, Giuseppe Valacchi5, Gianluca Giorgi1, Antonio Giordani6, Giovanna Poce7, Mariangela Biava7, Maurizio Anzini8.   

Abstract

A series of substituted 1,5-diarylpyrrole-3-alkoxyethyl ethers were previously synthesized and the potential anti-inflammatory and antinociceptive activities of these compounds were evaluated in vivo. The compounds displayed a very good activity against both carrageenan-induced hyperalgesia and oedema in the rat paw test. Therefore, in a very preliminary test, compounds (8a,b) showed antiproliferative activity in the HaCaT (aneuploid immortal keratinocyte from adult human skin) cell models. On these basis, our research continued with the synthesis of fluorinated derivatives (8c,d, 9b-d, and 10b-d) with the aim of improving the pharmacokinetic profile of the previous active compounds. Substitution of a hydrogen atom by a fluorine atom may change the conformational preferences of the molecules due to stereoelectronic effects and also fluorine atom may be able to exert the metabolic obstruction reducing the "first-pass effect". Compound 10b exhibited a prominent in vivo anti-inflammatory and antinociceptive activities, in addition its antiproliferative power in an in vitro model of human skin cancer is herein described.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  1,5-diarylpyrrole derivatives; Anti-inflammatory agents; Antinociceptive agents; Antiproliferative activity; COX-2 inhibitors; Molecular modelling

Mesh:

Substances:

Year:  2015        PMID: 26774035     DOI: 10.1016/j.ejmech.2015.12.044

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase Inhibitor.

Authors:  Thomas Fischer; Rainer Riedl
Journal:  ChemistryOpen       Date:  2017-01-12       Impact factor: 2.911

2.  Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.

Authors:  Chia-Chi Liu; Ching-Fang Yu; Shu-Chi Wang; Hsueh-Yin Li; Chiu-Min Lin; Hsia-Han Wang; Carmen Abate; Chi-Shiun Chiang
Journal:  BMC Cancer       Date:  2019-05-20       Impact factor: 4.430

3.  Design and Synthesis of Oligopeptidic Parvulin Inhibitors.

Authors:  Nicola Relitti; A Prasanth Saraswati; Gabriele Carullo; Alessandro Papa; Alessandra Monti; Rosaria Benedetti; Eugenia Passaro; Simone Brogi; Vincenzo Calderone; Stefania Butini; Sandra Gemma; Lucia Altucci; Giuseppe Campiani; Nunzianna Doti
Journal:  ChemMedChem       Date:  2022-04-26       Impact factor: 3.540

Review 4.  Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016).

Authors:  G Carullo; F Galligano; F Aiello
Journal:  Medchemcomm       Date:  2016-12-12       Impact factor: 3.597

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.